SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication | Scientific Reports - Nature.com
3/30/23 at 9:42am
Organization
Nature.com
42 words
0
Comments
Scientific Reports - Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication
Health
Biological Sciences
Pharmaceuticals & Biotech
Cancer
tumor eradication
Brachyury
CD40L
You are the first to view
https://www.nature.com/articles/s41598-023-32060-2
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...